Press Release
Beyond's analysis on Press Release
- — Company reports Q2 2026 double-digit sales growth and strong EPS growth, raising full-year 2026 guidance
- — Sanofi halts development of its OX40‑ligand antibody amlitelimab for atopic dermatitis, ending a key immuno‑inflammation program
Recent news mentioning Press Release
- — Lunai Bioworks (NASDAQ: LNAI) Issues Correction to Press Release Regarding Second Amended Complaint
- — 12 Top Press Releases from August
- — 12 Press Releases You Need to See This Week
- — The Justice Department in its press release allowed the SEC to hide the three inconvenient and undisputed facts, According to Attorney Lanny J. Davis
- — 11 Press Releases You Need to See This Week
- — 14 Press Releases You Need to See This Week
- — The boring press release machines learned to love
- — AURORA CANNABIS INC. RESPONDS TO PRESS RELEASE OF CURALEAF HOLDINGS, INC. REGARDING INTENTION TO LAUNCH UNSOLICITED TAKE-OVER BID
- — 13 Top Press Releases from July
- — Cision Wins 2026 MarTech Breakthrough Awards for Social Listening, Press Release Distribution, and AEO
- — Tripadvisor, Inc. Earnings Press Release Available on Company's Investor Relations Site
- — Press Release : Successful negotiations with financial partners. Maison Pommery & Associés secures its liquidity position. Exclusivity period with Henkell International ends without an agreement at this stage